Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Catalyst Pharmaceuticals, Inc.

Levi & Korsinsky announces it has commenced an investigation of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.

On February 17, 2016, Catalyst Pharmaceuticals announced the receipt of a “Refusal to File” letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application for Firdapse, its experimental drug treatment. According to the letter, the FDA found that the application was “not sufficiently complete.” Upon this news, shares of Catalyst Pharmaceuticals were down more than 35% on intraday trading on February 17, 2016. To obtain additional information, go to:

http://zlk.9nl.com/catalyst-pharmaceuticals-cprx

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.